Implications of cancer stem cells in the treatment of cancer

Chong-Xian Pan, Wei Zhu, Liang Cheng

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Identification of cancer stem cells (CSCs) in both hematological and solid malignancies suggests that CSCs may be a common phenomenon for most malignancies. Similarly to normal stem cells, CSCs can self-renew and differentiate into progeny cancer cells. Almost all current therapy against cancer targets differentiated cancer cells. CSCs are more resistant to therapy secondary to quiescence, increased expression of antiapoptotic proteins and drug efflux transporters. In this article, we review the current status of CSC research and propose the targeting of CSC cell-surface molecules, signal transduction pathways, the stem cell niche, stem cell differentiation and drug resistance.

Original languageEnglish (US)
Pages (from-to)723-731
Number of pages9
JournalFuture Oncology
Volume2
Issue number6
DOIs
StatePublished - Dec 2006

Fingerprint

Neoplastic Stem Cells
Neoplasms
Stem Cells
Stem Cell Niche
Stem Cell Research
Hematologic Neoplasms
Drug Resistance
Cell Differentiation
Signal Transduction
Therapeutics
Pharmaceutical Preparations
Proteins

Keywords

  • Cancer stem cell
  • Differentiation
  • Drug resistance
  • Stem cell
  • Stem cell niche
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Implications of cancer stem cells in the treatment of cancer. / Pan, Chong-Xian; Zhu, Wei; Cheng, Liang.

In: Future Oncology, Vol. 2, No. 6, 12.2006, p. 723-731.

Research output: Contribution to journalArticle

Pan, Chong-Xian ; Zhu, Wei ; Cheng, Liang. / Implications of cancer stem cells in the treatment of cancer. In: Future Oncology. 2006 ; Vol. 2, No. 6. pp. 723-731.
@article{f7b96ac911064141b8cf419c5c52478a,
title = "Implications of cancer stem cells in the treatment of cancer",
abstract = "Identification of cancer stem cells (CSCs) in both hematological and solid malignancies suggests that CSCs may be a common phenomenon for most malignancies. Similarly to normal stem cells, CSCs can self-renew and differentiate into progeny cancer cells. Almost all current therapy against cancer targets differentiated cancer cells. CSCs are more resistant to therapy secondary to quiescence, increased expression of antiapoptotic proteins and drug efflux transporters. In this article, we review the current status of CSC research and propose the targeting of CSC cell-surface molecules, signal transduction pathways, the stem cell niche, stem cell differentiation and drug resistance.",
keywords = "Cancer stem cell, Differentiation, Drug resistance, Stem cell, Stem cell niche, Targeted therapy",
author = "Chong-Xian Pan and Wei Zhu and Liang Cheng",
year = "2006",
month = "12",
doi = "10.2217/14796694.2.6.723",
language = "English (US)",
volume = "2",
pages = "723--731",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Implications of cancer stem cells in the treatment of cancer

AU - Pan, Chong-Xian

AU - Zhu, Wei

AU - Cheng, Liang

PY - 2006/12

Y1 - 2006/12

N2 - Identification of cancer stem cells (CSCs) in both hematological and solid malignancies suggests that CSCs may be a common phenomenon for most malignancies. Similarly to normal stem cells, CSCs can self-renew and differentiate into progeny cancer cells. Almost all current therapy against cancer targets differentiated cancer cells. CSCs are more resistant to therapy secondary to quiescence, increased expression of antiapoptotic proteins and drug efflux transporters. In this article, we review the current status of CSC research and propose the targeting of CSC cell-surface molecules, signal transduction pathways, the stem cell niche, stem cell differentiation and drug resistance.

AB - Identification of cancer stem cells (CSCs) in both hematological and solid malignancies suggests that CSCs may be a common phenomenon for most malignancies. Similarly to normal stem cells, CSCs can self-renew and differentiate into progeny cancer cells. Almost all current therapy against cancer targets differentiated cancer cells. CSCs are more resistant to therapy secondary to quiescence, increased expression of antiapoptotic proteins and drug efflux transporters. In this article, we review the current status of CSC research and propose the targeting of CSC cell-surface molecules, signal transduction pathways, the stem cell niche, stem cell differentiation and drug resistance.

KW - Cancer stem cell

KW - Differentiation

KW - Drug resistance

KW - Stem cell

KW - Stem cell niche

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=33845639918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845639918&partnerID=8YFLogxK

U2 - 10.2217/14796694.2.6.723

DO - 10.2217/14796694.2.6.723

M3 - Article

VL - 2

SP - 723

EP - 731

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 6

ER -